Clinical Trials

132 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT04941937 2023-02-27

Selinexor in Combination With Immunomodulator （Thalidomide/Pomalidomide/Lenalidomide）in RRMM

90 enrolled

Multiple Myeloma

NCT05266820 2022-03-18

Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer

120 enrolled

Colorectal Neoplasms

NCT04382300 2021-01-28

Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions

39 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02733380 2020-04-01

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

20 enrolled

Lymphoid

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03062800 2019-06-05

Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)

232 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03143036 2018-06-07

Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma

100 enrolled

Recurrence, Neoplasms, Plasma Cell

NCT03341494 2017-11-14

EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide

128 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03335098 2017-11-07

BOMB-THROW

15 enrolled

Lymphoid

Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone

NCT03204019 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

60 enrolled

Adenoma, Islet Cell

NCT03204032 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

EndocrineGastrointestinalNET

60 enrolled

Extrapancreatic Neuroendocrine Tumor

NCT01551641 2016-02-17

Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer

180 enrolled

Esophageal Neoplasms

NCT02649101 2016-01-07

Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer

60 enrolled

Breast

Breast Neoplasms

NCT00026416 2014-01-06

Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma

Sarcoma

Sarcoma, Osteosarcoma

NCT00033709 2014-01-06

Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma

Sarcoma

Leiomyosarcoma, Sarcoma

NCT00276705 2013-09-17

Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer

47 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00958854 2013-08-26

Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma

37 enrolled

Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma

NCT00027664 2013-08-07

Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer

90 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01114048 2011-09-22

KMM-97

78 enrolled

Multiple Myeloma

NCT00124813 2010-02-02

Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma

80 enrolled

Multiple Myeloma

NCT00890188 2009-05-07

UFUR

34 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT00438841 2009-03-13

Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma

43 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00349115 2008-05-06

TCD Followed by autoSCT for Newly Diagnosed MM Patients

43 enrolled

Multiple Myeloma

NCT00521482 2007-08-28

Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma

40 enrolled

CNS

Glioblastoma, Recurrence

NCT00319865 2006-04-27

PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma

47 enrolled

Multiple Myeloma

NCT00006198 2005-06-24

Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer

Liver Neoplasms

NCT00006200 2005-06-24

Thalidomide and Dacarbazine for Metastatic Melanoma